Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;33(12):108089.
doi: 10.1016/j.jstrokecerebrovasdis.2024.108089. Epub 2024 Oct 13.

Transcarotid arterial revascularization for symptomatic carotid web

Affiliations

Transcarotid arterial revascularization for symptomatic carotid web

Cameron Ayala et al. J Stroke Cerebrovasc Dis. 2024 Dec.

Abstract

Objectives: Symptomatic carotid web is an increasingly recognized cause of acute ischemic stroke with a high risk of recurrent ischemic events despite aggressive medical interventions. Surgical interventions including transfemoral carotid artery stenting (TFCAS) and carotid endarterectomy have been described to reduce this risk, but transcarotid arterial revascularization (TCAR) has not been evaluated for this purpose.

Materials and methods: Patients with cerebral ischemia from carotid web underwent TCAR with flow reversal. Patients were monitored for periprocedural complications and assessed at follow-up for clinical evidence of recurrent ischemia.

Results: Six cases over the course of 21 months were identified, 2 males and 4 females with a median age of 59.5 (interquartile range of 39). All underwent technically successful TCAR without periprocedural complications no post-procedural cerebral ischemia over a median follow-up time of 21 months.

Conclusions: In this small series of patients, TCAR provided a safe and effective treatment of carotid webs that had previously caused cerebral ischemia.

Keywords: Carotid stenosis; Revascularization; Stroke; Symptomatic carotid web; TCAR; Transcarotid arterial revascularization; Vascular disorders.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Radmehr Torabi reports a relationship with Silk Road Medical that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

MeSH terms

LinkOut - more resources